pharmaceutical companies

Process Analytical Technology (PAT): Measuring Return on Investment

Pharmaceutical companies therefore need to investigate the investment in planning for a potentially different manufacturing future as well as responding to pressures on their current manufacturing set-up. Manufacturing Infrastructure Once they have... Pharma Asia
Drug Manufacturing

Outsourcing in China and India: A Comparison

pharmaceutical companies are typically staffed by 300-500 researchers. For example, the Shanghai R&D centers of both GSK and Novartis have about 500 scientists. Pfizer’s Shanghai center has about 350 scientists. Roche’s R&D center in the same city... Pharma Asia
Drug Development

Roche Engages In Four Additional AIDS Technology Transfers In World’s Poorest Countries

Roche announced it has entered into four new technology transfers with local manufacturing companies in Africa and Asia; Regal Pharmaceuticals in Kenya, CAPS Holdings in Zimbabwe, Shelys Pharmaceuticals in Tanzania and Beximco Pharmaceuticals Ltd in ... Pharma Asia
Drug Manufacturing

KPMG Reports India's Rosy Future In Pharmaceuticals

India's pharmaceutical industry is well positioned for sustainable growth and expansion, according to KPMG – CII Report titled, “Indian Pharma Inc. – A Continuing Success Story” released at the Pharma Summit 2007. The industry has grown at a ... Pharma Asia
Drug Manufacturing

Asian API Manufacturers Look to Optimize Quality, Safety and Efficiency

pharmaceutical companies are primarily oriented towards supplying their own domestic market. Thus, they tend to place less emphasis on external GMP compliance. Indian API manufacturers, on the other hand, are focused on export sales to highly regulated... Pharma Asia
Drug Manufacturing

Report: Global Pharmaceutical Market to Double in Value to US$1.3 Trillion by 2020

Pharmaceutical companies are facing a dearth of new compounds in the pipeline, poor share value performance, rising sales and marketing expenditures, increased legal and regulatory constraints and tarnished reputations. "The pharma industry will not... Pharma Asia
Drug Manufacturing

Regulation of Chemical Substances in Europe: What it Means for the Pharmaceutical Industry

pharmaceutical companies should eliminate the use of SVHCs as early as possible in their drug development processes. Restriction can apply to all substances, without volume limits. Such substances and their restriction details are described in the... Pharma Asia

Supply Chain Management: Combating Counterfeits

The pharmaceuticals drug supply chain from the manufacturer to the pharmacy usually includes several intermediaries such as wholesalers and distributors. This opens the supply chain to the risk of counterfeit drugs and encourages parallel trade, leading ... Pharma Asia
Drug Delivery

TFS Improves Functionality of Darwin LIMS v 2.0

pharmaceutical companies, the Darwin LIMS provides stability management, product and batch management, and system interfacing. Environmental monitoring function, critical to compliance and quality assurance, includes test allocations for monitoring sampling... ECN Asia
Software

Outsourcing: Meeting Standards

Pharmaceutical companies have heard the complaints of consumers and those of angry regulatory agencies. These companies and are actively moving to put into place an infrastructure which will control the quality of the companies they work with on an international... Pharma Asia

 < Previous   1   2   3   4  5  6   7   8   9   10   Next > 

Related Videos

Pharmaceutical CompanyCheck Out Local.com To FindLocal.com

Biotech Jobs & Careers.Find Science & Biotech Jobs.www.CareerBuilder.com/Biotech_Jobs

Local Jobs (Now Hiring)Find Pharmaceutical Jobs now!www.JobsWire.com

Pharmaceutical Rep WantedConnecting Nationwide ManufacturersManufacturers-Representatives.com

Pharmaceutical JobsNew Pharmaceutical Jobs listedwww.iHirePharmacy.com